• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,918.76 394.50
( 0.54%)
Global Indices
Nasdaq
50,812.84 -74.94
(-0.15%)
Dow Jones
7,426.81 22.07
(0.30%)
Hang Seng
65,160.26 1,135.66
(1.77%)
Nikkei 225
10,242.24 -130.96
(-1.26%)
Forex
USD-INR
95.22 -0.51
(-0.53%)
EUR-INR
109.67 -1.54
(-1.39%)
GBP-INR
126.98 -1.60
(-1.25%)
JPY-INR
0.59 0.00
(-0.77%)

EQUITY - MARKET SCREENER

Lupin Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500257
INE326A01037
659.0470742
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LUPIN
17.08
102996.2
EPS(TTM)
Face Value()
Div & Yield %
131.91
2
0.8
 

As on: Jun 09, 2026 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
2,263.40 10.80 312498 17.08
Stock Price Details
Open Price() 2,253.60
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 2,271.15
Today's Low () 2,248.00
52-Week High () 2492
152-Week Low () 1838.65
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.80
Eps 131.91
Book Value 659.0470742
Market Cap (.Cr) 102,996.20
Face Value 2
Market Lot 1
AGM Date Aug
Book Closure Date
ISIN No. INE326A01037


News
Lupin partners with Spain’s ERN for launch of asthma, COPD inhaler Luforbec
Lupin launches Luforbec® inhaler in Spain
Lupin gains after receiving USFDA nod for Ranluspec
Lupin and alliance partner Natco receive USFDA approval for Eribulin Mesylate Injection
Lupin receives Establishment Inspection Report for its Ankleshwar unit
Lupin features in Dow Jones Best-in-Class (DJBIC) indices
Board of Lupin recommends final dividend
Lupin consolidated net profit rises 89.04% in the March 2026 quarter
Lupin Q4 PAT jumps 87.72%; EBITDA margin expands 1,070 bps
Lupin wins USFDA approval for Glycerol Phenylbutyrate oral liquid
More
Corporate Details
Incoporation Year   : 1983
Chairman : M D Gupta
Bussiness Group : Indian Private
Registered Office
Lupin Ltd
Kalpataru Inspire 3rd Floor,
Off Western Exp HW Santacruz-E,
Mumbai,
Maharashtra-400055
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-22-6640 2323
Fax:91-22-6640 8131
Fax:91-22-66317458
E-Mail : investorservices@lupinpharma.com
URL : https://www.lupin.com/


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 100
  • BSE 500
  • BSE 200
  • BSE HC
  • BSE DOLLEX
  • BSE Shariah 50
  • CNX 500
  • Nifty Midcap50
  • CNX Midcap
  • CNX Pharma
  • CNX 200
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi